NCT02906644View on ClinicalTrials.gov

Combination Nicotine Patch / Lorcaserin for Smoking Cessation

PHASE2CompletedINTERVENTIONAL

Enrollment

97

Participants

Timeline

Start Date

November 8, 2016

Primary Completion Date

March 27, 2018

Study Completion Date

October 18, 2018

Conditions

Nicotine Dependence

Interventions

DRUG

lorcaserin

DRUG

nicotine patch

DRUG

placebo lorcaserin

Trial Locations (1)

27705

Duke Center for Smoking Cessation, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Duke University

OTHER

NCT02906644 - Combination Nicotine Patch / Lorcaserin for Smoking Cessation | Biotech Hunter | Biotech Hunter